DENTSPLY SIRONA (XRAY) Releases Quarterly Earnings Results

DENTSPLY SIRONA (NASDAQ:XRAY) released its quarterly earnings results on Thursday. The medical instruments supplier reported $0.38 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.46 by ($0.08), RTT News reports. DENTSPLY SIRONA had a positive return on equity of 9.12% and a negative net margin of 39.62%. The firm had revenue of $928.40 million for the quarter, compared to analyst estimates of $951.58 million. During the same period in the prior year, the business earned $0.70 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was down 8.0% on a year-over-year basis. DENTSPLY SIRONA updated its FY 2018 guidance to $2.00 EPS and its FY18 guidance to $2.00-2.15 EPS.

NASDAQ XRAY traded down $0.78 during mid-day trading on Friday, hitting $36.02. The company’s stock had a trading volume of 526,463 shares, compared to its average volume of 2,921,909. DENTSPLY SIRONA has a 52-week low of $33.93 and a 52-week high of $68.98. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.10 and a current ratio of 1.69. The firm has a market capitalization of $7.90 billion, a price-to-earnings ratio of 13.53, a PEG ratio of 2.06 and a beta of 1.15.

Several equities research analysts recently issued reports on the stock. Zacks Investment Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Monday, August 6th. Robert W. Baird cut shares of DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and decreased their target price for the stock from $56.00 to $38.00 in a research report on Tuesday, August 7th. BidaskClub raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Tuesday, July 31st. Barrington Research cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, August 9th. Finally, HC Wainwright set a $40.00 target price on shares of DENTSPLY SIRONA and gave the stock a “hold” rating in a research report on Friday, August 31st. Three analysts have rated the stock with a sell rating, eight have assigned a hold rating and six have given a buy rating to the stock. DENTSPLY SIRONA has an average rating of “Hold” and an average target price of $51.50.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. MAI Capital Management raised its holdings in DENTSPLY SIRONA by 27.2% in the second quarter. MAI Capital Management now owns 6,159 shares of the medical instruments supplier’s stock valued at $270,000 after buying an additional 1,316 shares during the period. Northwest Investment Counselors LLC raised its holdings in DENTSPLY SIRONA by 21.0% in the second quarter. Northwest Investment Counselors LLC now owns 7,582 shares of the medical instruments supplier’s stock valued at $332,000 after buying an additional 1,318 shares during the period. CIBC Asset Management Inc raised its holdings in DENTSPLY SIRONA by 4.7% in the second quarter. CIBC Asset Management Inc now owns 29,581 shares of the medical instruments supplier’s stock valued at $1,295,000 after buying an additional 1,330 shares during the period. Exane Asset Management raised its holdings in DENTSPLY SIRONA by 41.3% in the second quarter. Exane Asset Management now owns 4,678 shares of the medical instruments supplier’s stock valued at $205,000 after buying an additional 1,368 shares during the period. Finally, Comerica Bank raised its holdings in DENTSPLY SIRONA by 2.3% in the second quarter. Comerica Bank now owns 61,333 shares of the medical instruments supplier’s stock valued at $2,803,000 after buying an additional 1,400 shares during the period. Hedge funds and other institutional investors own 97.90% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “DENTSPLY SIRONA (XRAY) Releases Quarterly Earnings Results” was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this article on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://sportsperspectives.com/2018/11/09/dentsply-sirona-xray-releases-quarterly-earnings-results.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: Outstanding Shares

Earnings History for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply